Exagen (XGN) Shareholder's Equity Growth (1y) (2019 - 2026)
Exagen (XGN) Shareholder's Equity Growth (1y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn |
| 10 | Exagen | 101.38 Mn | 79.87 Mn | 10.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125.39% |
| Dec 31, 2025 | 82.90% |
| Sep 30, 2025 | 40.95% |
| Jun 30, 2025 | 19.61% |
| Mar 31, 2025 | -67.97% |
| Dec 31, 2024 | -57.96% |
| Sep 30, 2024 | -53.21% |
| Jun 30, 2024 | -44.88% |
| Mar 31, 2024 | -44.37% |
| Dec 31, 2023 | -46.55% |
| Sep 30, 2023 | -51.05% |
| Jun 30, 2023 | -49.22% |
| Mar 31, 2023 | -52.81% |
| Dec 31, 2022 | -50.01% |
| Sep 30, 2022 | -38.12% |
| Jun 30, 2022 | -34.82% |
| Mar 31, 2022 | -24.95% |
| Dec 31, 2021 | 103.01% |
| Sep 30, 2021 | 104.17% |
| Jun 30, 2021 | 101.46% |